• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

0.1%他扎罗汀乳膏与0.05%丙酸氯倍他索乳膏治疗慢性斑块状银屑病的临床疗效比较:一项双盲、随机、左右对照研究。

Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.

作者信息

Angelo Joe S, Kar Bikash Ranjan, Thomas Jayakar

机构信息

Department of Dermatology, SLR and TC, Karigiri, Vellore, India.

出版信息

Indian J Dermatol Venereol Leprol. 2007 Jan-Feb;73(1):65. doi: 10.4103/0378-6323.30663.

DOI:10.4103/0378-6323.30663
PMID:17319037
Abstract

BACKGROUND

No controlled data is available till date comparing topical tazarotene and clobetasol in Indian psoriatic patients.

OBJECTIVE

The aim was to compare the clinical efficacy of 12 weeks of once-daily tazarotene 0.1% cream with that of once-daily clobetasol propionate 0.05% cream in the treatment of patients with chronic plaque psoriasis.

METHODS

About 36 patients with bilaterally symmetrical lesions were enrolled in this double-blind randomized controlled study. A left-right randomized study was conducted.

RESULTS

Clobetasol cream was better than tazarotene cream in reducing the erythema throughout the treatment period with statistically significant differences favoring clobetasol at weeks 2, 4, 6 and 8 ( P <0.05). Tazarotene was better in reducing the induration at weeks 2 ( P <0.05), 4, 10 and 12. Clobetasol cream was better in reducing the scaling throughout the treatment period with statistically significant differences favoring clobetasol over the entire treatment period. Treatment success rate was 100% with clobetasol and 88% with tazarotene at the end of week 12 with clobetasol achieving 100% success rate at the end of week 6. Treatment with tazarotene resulted in uniform reduction of plaque elevation and was not associated with the development of hot spots.

CONCLUSION

Topical tazarotene 0.1% cream is less effective than topical clobetasol propionate 0.05% cream in the treatment of plaque psoriasis. It has more effect on induration than on erythema and scaling of psoriatic lesions.

摘要

背景

迄今为止,尚无对照数据可用于比较印度银屑病患者使用外用他扎罗汀和丙酸氯倍他索的情况。

目的

本研究旨在比较0.1%他扎罗汀乳膏每日一次使用12周与0.05%丙酸氯倍他索乳膏每日一次治疗慢性斑块状银屑病患者的临床疗效。

方法

约36例双侧对称皮损患者纳入本双盲随机对照研究。进行了一项左右随机研究。

结果

在整个治疗期间,丙酸氯倍他索乳膏在减轻红斑方面优于他扎罗汀乳膏,在第2、4、6和8周差异有统计学意义,支持丙酸氯倍他索(P<0.05)。他扎罗汀在第2周(P<0.05)、第4、10和12周减轻硬结方面效果更好。丙酸氯倍他索乳膏在整个治疗期间减轻鳞屑方面效果更好,在整个治疗期间差异有统计学意义,支持丙酸氯倍他索。在第12周结束时,丙酸氯倍他索的治疗成功率为100%,他扎罗汀为88%,丙酸氯倍他索在第6周结束时成功率达到100%。使用他扎罗汀治疗可使斑块隆起均匀降低,且未出现热点。

结论

0.1%他扎罗汀外用乳膏在治疗斑块状银屑病方面不如0.05%丙酸氯倍他索外用乳膏有效。它对银屑病皮损硬结的影响大于对红斑和鳞屑的影响。

相似文献

1
Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.0.1%他扎罗汀乳膏与0.05%丙酸氯倍他索乳膏治疗慢性斑块状银屑病的临床疗效比较:一项双盲、随机、左右对照研究。
Indian J Dermatol Venereol Leprol. 2007 Jan-Feb;73(1):65. doi: 10.4103/0378-6323.30663.
2
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.一项评估卤米松/他扎罗汀固定组合治疗斑块状银屑病安全性和有效性的2期、多中心、双盲、随机、赋形剂对照临床研究。
J Drugs Dermatol. 2017 Mar 1;16(3):197-204.
3
A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.每日一次外用0.1%他扎罗汀凝胶联合每日一次外用0.1%糠酸莫米松乳膏与每日两次外用0.005%卡泊三醇软膏治疗斑块状银屑病的疗效比较。
Clin Ther. 2000 Oct;22(10):1225-38. doi: 10.1016/s0149-2918(00)83065-9.
4
Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.卡泊三醇(达力士)软膏与他扎罗汀(他扎罗汀)凝胶联合使用与氯倍他索软膏治疗斑块状银屑病的对比:一项初步研究。
J Am Acad Dermatol. 2002 Jun;46(6):907-13. doi: 10.1067/mjd.2002.120453.
5
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.每日一次的他扎罗汀凝胶与每日两次的氟轻松乳膏治疗斑块状银屑病的对比
J Am Acad Dermatol. 1998 May;38(5 Pt 1):705-11. doi: 10.1016/s0190-9622(98)70594-8.
6
Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.0.01% 卤倍他索/0.045% 他扎罗汀固定组合治疗重度局限性斑块状银屑病的疗效、安全性及耐受性:两项III期随机对照试验的事后分析
J Drugs Dermatol. 2019 Oct 1;18(10):1012-1018.
7
Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.0.1%他扎罗汀乳膏与0.05%丙酸氯倍他索乳膏治疗银屑病甲的双盲研究。
Acta Derm Venereol. 2007;87(2):167-8. doi: 10.2340/00015555-0195.
8
Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.0.01%卤倍他索/0.045%他扎罗汀洗剂治疗中度至重度斑块状银屑病:治疗停止后的疗效维持
J Drugs Dermatol. 2019 Aug 1;18(8):815-820.
9
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.固定剂量卤倍他索-他扎罗汀复方制剂治疗中重度斑块状银屑病的安全性和疗效:两项 3 期随机对照研究结果。
J Am Acad Dermatol. 2018 Aug;79(2):287-293. doi: 10.1016/j.jaad.2018.03.040. Epub 2018 Apr 1.
10
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.他扎罗汀乳膏治疗银屑病:两项多中心、双盲、随机、赋形剂对照研究,评估0.05%和0.1%他扎罗汀乳膏每日一次外用12周的安全性和有效性。
J Am Acad Dermatol. 2003 May;48(5):760-7. doi: 10.1067/mjd.2003.103.

引用本文的文献

1
Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors.免疫检查点抑制剂相关的具有挑战性的皮肤科问题。
Am J Clin Dermatol. 2022 Sep;23(5):707-717. doi: 10.1007/s40257-022-00706-y. Epub 2022 Jun 16.
2
Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach.皮肤科外用糖皮质激素的应用:循证医学方法
Indian J Dermatol. 2017 May-Jun;62(3):237-250. doi: 10.4103/ijd.IJD_169_17.
3
Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study.
外用0.1%他扎罗汀乳膏治疗掌跖银屑病的评估:一项观察者盲法随机对照研究。
Indian J Dermatol. 2011 Jan;56(1):40-3. doi: 10.4103/0019-5154.77550.